share_log

Confluent | 8-K: Current report

SEC ·  Sep 16, 2024 21:06

Summary by Moomoo AI

Confluent has appointed Kong Phan as its new Chief Accounting Officer and principal accounting officer, effective September 13, 2024. Phan, 42, previously served as Confluent's Corporate Controller from April 2017 to September 2024. He succeeds Rohan Sivaram, who continues as Chief Financial Officer and principal financial officer.Phan's promotion package includes an annual base salary of $350,000, a target bonus of 50% of base salary, and restricted stock units valued at $1,340,000. The RSUs will vest quarterly over two years, beginning December 20, 2024. Phan brings extensive accounting experience from roles at Polyvore Inc., Electronic Arts, Gap Inc., and Ernst & Young, LLP.The appointment, announced on September 12, 2024, involves no family relationships or related transactions requiring disclosure. Phan will sign Confluent's standard indemnification agreement for executives.
Confluent has appointed Kong Phan as its new Chief Accounting Officer and principal accounting officer, effective September 13, 2024. Phan, 42, previously served as Confluent's Corporate Controller from April 2017 to September 2024. He succeeds Rohan Sivaram, who continues as Chief Financial Officer and principal financial officer.Phan's promotion package includes an annual base salary of $350,000, a target bonus of 50% of base salary, and restricted stock units valued at $1,340,000. The RSUs will vest quarterly over two years, beginning December 20, 2024. Phan brings extensive accounting experience from roles at Polyvore Inc., Electronic Arts, Gap Inc., and Ernst & Young, LLP.The appointment, announced on September 12, 2024, involves no family relationships or related transactions requiring disclosure. Phan will sign Confluent's standard indemnification agreement for executives.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more